Close
Digital Health & Ai Innovation summit 2026
APE 2026

Integra LifeSciences Announces Three-Year Contract With Novation to Provide Luxtec(R) Surgical Headl

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Konica Minolta and deepc AI Partnership...

Konica Minolta Healthcare Americas and deepc have formed a...

Medtronic Wins FDA Clearance for MiniMed...

Medtronic has received U.S. Food and Drug Administration (FDA)...

Novartis Plans its Fourth US Radioligand...

Novartis, which is a world-leading innovative medicines company, has...
Integra LifeSciences Holdings Corporation announced that it has signed a three-year contract with Novation, the leading healthcare supply contracting company, to provide Luxtec® surgical headlights, light sources and accessories to the members of VHA Inc., University HealthSystem Consortium (UHC) and Provista.

Dan Reuvers, President, Integra Surgical said, We are pleased that Novation has shown such confidence in Integra by selecting us as their exclusive contract partner for headlights. Integra is one of the world’s largest suppliers of surgical lighting systems, and our products will help limit uncertainty for the members served by Novation by ensuring that they have the optimal visualization for each surgical procedure.

Latest stories

Related stories

Konica Minolta and deepc AI Partnership Expands Exa Platform

Konica Minolta Healthcare Americas and deepc have formed a...

Medtronic Wins FDA Clearance for MiniMed Go Smart MDI System

Medtronic has received U.S. Food and Drug Administration (FDA)...

Novartis Plans its Fourth US Radioligand Therapy Facility

Novartis, which is a world-leading innovative medicines company, has...

Tempus-NYU Langone Collaboration Advances Precision Oncology

Tempus and NYU Langone Health have signed a multi-year...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »